Notice of Appeal | Aug 29, 2019 | PAPER | PETITIONER |
FINAL WRITTEN DECISION
35 U.S.C. sec 318(a); 37 C.F.R. sec 42.73 | Jul 3, 2019 | PAPER | BOARD |
Joint Errata Sheet for Oral Hearing Transcript | Jun 11, 2019 | PAPER | PETITIONER |
ORDER
Hearing Transcript Errata Requested by Parties
37 C.F.R. § 42.5(a) | Jun 6, 2019 | PAPER | BOARD |
Hearing Transcript | May 30, 2019 | PAPER | BOARD |
Petitioner's Demonstrative Exhibits | Apr 2, 2019 | EXHIBIT | PETITIONER |
Patent Owner's Demonstratives for Oral Hearing | Apr 2, 2019 | PAPER | PATENT OWNER |
Patent Owner Reply to Motion to Exclude | Mar 21, 2019 | PAPER | PATENT OWNER |
Petitioner's Reply in Support of Motion to Exclude | Mar 21, 2019 | PAPER | PETITIONER |
ORDER Conduct of Proceeding | Mar 21, 2019 | PAPER | BOARD |
Patent Owner's Opposition to Petitioner's Motion to Exclude | Mar 15, 2019 | PAPER | PATENT OWNER |
Petitioner's Response to Patent Owner's Sur-Reply | Mar 15, 2019 | PAPER | PETITIONER |
Petitioner's Opposition to Patent Owner's Motion to Exclude Evidence | Mar 15, 2019 | PAPER | PETITIONER |
KVK-TECH Exhibit 1058 Corrected Declaration of James McCracken, MD | Mar 15, 2019 | EXHIBIT | PETITIONER |
KVK-TECH Exhibit 1060 Declaration of Steven Roth | Mar 15, 2019 | PAPER | PETITIONER |
Patent Owner's Sur-Reply | Mar 7, 2019 | PAPER | PATENT OWNER |
Order Re. Ex Parte Communication | Mar 7, 2019 | PAPER | BOARD |
2083 - McCracken Exhibit 614 | Mar 7, 2019 | EXHIBIT | PATENT OWNER |
2084 - McCracken Exhibit 612 | Mar 7, 2019 | EXHIBIT | PATENT OWNER |
2082 - McCracken, MD Deposition Transcript | Mar 7, 2019 | EXHIBIT | PATENT OWNER |
2085 - McCracken Exhibit 615 | Mar 7, 2019 | EXHIBIT | PATENT OWNER |
Patent Owner's Motion to Exclude Exhibits 1047, 1049, 1051, & 1054-1054 | Mar 7, 2019 | PAPER | PATENT OWNER |
Patent Owner's Request for Oral Argument | Mar 7, 2019 | PAPER | PATENT OWNER |
Petitioner's Motion to Exclude | Mar 7, 2019 | PAPER | PETITIONER |
Petitioner's Request for Oral Argument | Mar 7, 2019 | PAPER | PETITIONER |
Updated Power of Attorney | Feb 28, 2019 | PAPER | PETITIONER |
Updated Mandatory Notice as to Lead and Backup Counsel | Feb 28, 2019 | PAPER | PETITIONER |
Granting Parties’ Request for Authorization to File Briefing in Lieu of Observations
37 C.F.R. §§ 42.5(a), 42.24(c)(1) | Feb 25, 2019 | PAPER | BOARD |
Patent Owner's Notice of Deposition of James T. McCracken | Feb 20, 2019 | PAPER | PATENT OWNER |
Patent Owner Objections to Petitioner's Reply Evidence | Feb 14, 2019 | PAPER | PATENT OWNER |
Decision Granting Petitioner's Motion for Admission Pro Hac Vice of
David J. Galluzzo | Feb 14, 2019 | PAPER | BOARD |
Granting Patent Owner's Request for Authorization to File a Sur-Reply | Feb 14, 2019 | PAPER | BOARD |
Petitioner Reply | Feb 7, 2019 | PAPER | PETITIONER |
Declaration of James McCracken | Feb 7, 2019 | EXHIBIT | PETITIONER |
1046 - Polli Deposition Tr | Feb 7, 2019 | EXHIBIT | PETITIONER |
1047 - Polli Deposition Exhibit 100 Adderall XR Pharmacology Review | Feb 7, 2019 | EXHIBIT | PETITIONER |
1048 - Polli Deposition Exhibit 101 US Patent RE41,148 | Feb 7, 2019 | EXHIBIT | PETITIONER |
1049 - Adderall XR Chemistry Review | Feb 7, 2019 | EXHIBIT | PETITIONER |
1050 - Mydayis Approvable Letter | Feb 7, 2019 | EXHIBIT | PETITIONER |
1051 - Mydayis Summary Review | Feb 7, 2019 | EXHIBIT | PETITIONER |
1052 - Pelham | Feb 7, 2019 | EXHIBIT | PETITIONER |
1053 - James | Feb 7, 2019 | EXHIBIT | PETITIONER |
1054 - Dexedrine Label | Feb 7, 2019 | EXHIBIT | PETITIONER |
1055 - Dyanavel XR Label | Feb 7, 2019 | EXHIBIT | PETITIONER |
1056 - Adzenys ER Label | Feb 7, 2019 | EXHIBIT | PETITIONER |
1057 - McGough | Feb 7, 2019 | EXHIBIT | PETITIONER |
Updated Mandatory Notice as to Lead and Backup Counsel | Jan 24, 2019 | PAPER | PETITIONER |
Power of Attorney | Jan 24, 2019 | PAPER | PETITIONER |
Motion for Admission Pro Hac Vice of David J. Galluzzo | Jan 24, 2019 | PAPER | PETITIONER |
Declaration of David J. Galluzzo in Support of Motion for Admission Pro Hac Vice | Jan 24, 2019 | EXHIBIT | PETITIONER |
Patent Owner Updated Mandatory Notices | Jan 22, 2019 | PAPER | PATENT OWNER |
Errata of James E. Polli Declaration, Ph.D. | Jan 17, 2019 | EXHIBIT | PATENT OWNER |
DECISION
Granting Petitioner’s Motion to Withdraw and Substitute Counsel
37 C.F.R. § 42.10 | Jan 15, 2019 | PAPER | BOARD |
PETITIONER¿¿¿S NOTICE OF DEPOSITION OF DR. JAMES E. POLLI PURSUANT TO 37 C.F.R. ¿¿ 42.53(d)(4) | Jan 7, 2019 | PAPER | PETITIONER |
PETITIONER KVK-TECH, INC.'S MOTION FOR WITHDRAWAL AND SUBSTITUTION OF COUNSEL | Dec 17, 2018 | PAPER | PETITIONER |
Petitioner's Updated Mandatory Notice Regarding Removal of Back-Up Counsel | Nov 28, 2018 | PAPER | PETITIONER |
Petitioner's Power of Attorney Appointing Additional Back-Up Counsel | Nov 16, 2018 | PAPER | PETITIONER |
Petitioner's Updated Mandatory Notice Regarding Additional Back-Up Counsel | Nov 16, 2018 | PAPER | PETITIONER |
Patent Owner Updated Mandatory Notices | Oct 24, 2018 | PAPER | PATENT OWNER |
Declaration of James E. Polli, Ph.D. | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Swanson, Canadian Child Adolesc. Psych. Re. 1 4-3 (2005) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Goodman & Gilman, 9th ed (1996) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Remington, 20th ed. (2000), Pharmaceutical Care | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Jusko Deposition Exhibit. 304, Levy, Case History of a Pharmaceutical Formulation Failure, Clinical Pharmacology & Therapeutics, 8(6) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
BURGESS DEPOSITION TRANSCRIPT (September 24, 2018) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Burgess Deposition Exhibit 200 (Statement regarding drug doses) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Jusko Deposition Exhibit 306, Mager et al., Drug Metabolism Pharmacokinetics, 24(1): 16-24 (2009) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Jusko Deposition Exhibit 310, Jusko, W. J., Symposium on Pediatric Pharmacology, Pediatric Clinics of North America, 19(1) (1972) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Patent Owner Response | Oct 23, 2018 | PAPER | PATENT OWNER |
Ansel, Popovich & Allen 6th, Ch. 3-5 (1995) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Brauer J. Clin. Pharm. 16-1 72-76 (1996) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Handbook of Pharmaceutical Excipients, 4th ed. (2003), Preface | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Brown, J. Am. Acad. Child Psych. (19) 225-239 (1980) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Jusko Deposition Exhibit 305, Findling, Journal of Psychopharmacology, 30(4):404-410 (2010) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Jusko Deposition Exhibit 307, Jusko, Foundations of Pharmacodynamic Systems Analysis, 161-175 (2016) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Jusko Deposition Exhibit 309, Guidelines for Collection and Analysis of Pharmacokinetic, 8-29 (2006) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
JUSKO DEPOSITION TRANSCRIPT (September 27, 2018) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Jusko Deposition Exhibit 303, Levy et al., Journal of Pharmaceutical Sciences, 58(4) (1969) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Jusko Deposition Exhibit 308, Sharma et al., Journal of Pharmacokinetics and Biopharmaceutics, 24(6): 611-635 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Mendyk et al., Dissolution Technologies, May 2015 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Shen and Burgess, J. Control Release, 2015 December 10; 219, 644-51 | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
AstraZeneca Pharms. LP v. Anchen Pharms., 2012 US Dist LEXIS 43989 (2012) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
U.S. Pharmacopeia 24, pp. 1629-1631 (2000) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Dokoumetzidis, International J. Pharm., 321, 1-11 (2006) | Oct 23, 2018 | EXHIBIT | PATENT OWNER |
Burgess Declaration Errata Sheet | Oct 22, 2018 | EXHIBIT | PETITIONER |
Jusko Declaration Errata Sheet | Oct 22, 2018 | EXHIBIT | PETITIONER |
Notice of Deposition of Diane J. Burgess | Sep 20, 2018 | PAPER | PATENT OWNER |
Notice of Deposition of William J. Jusko | Sep 20, 2018 | PAPER | PATENT OWNER |
DECISION Granting Petitioner's Motions for Admission Pro Hac Vice of Thomas Hedemann and Chad Landmon | Aug 13, 2018 | PAPER | BOARD |
Patent Owner's Notice of Stipulation Regarding Scheduling Order | Aug 3, 2018 | PAPER | PATENT OWNER |
SCHEDULING ORDER | Jul 10, 2018 | PAPER | BOARD |
Trial Instituted Document | Jul 6, 2018 | PAPER | BOARD |
Second Corrected Certificate of Service for Patent Owner Preliminary Response | Apr 13, 2018 | PAPER | PATENT OWNER |
Patent Owner's Corrected Certificate of Service | Apr 11, 2018 | PAPER | PATENT OWNER |
DECLARATION OF SARA ROSENBAUM, Ph.D. (with CV) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
MYDAYIS¿¿ FDA Label (06-2017) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
MYDAYIS¿¿ Website Pages | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Excerpts from Merck, 11th Ed | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Stempel, 7th Ed. - Dispensing of Medication (1971) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Patrick, Human Psychopharmacology, 12_527-546 (1997) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Gibaldi, Biopharmaceutics & Clinical Pharmacokinetics, Ch.1 (1991) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Patent Owner's Preliminary Response [Confidential] | Apr 10, 2018 | PAPER | PATENT OWNER |
Gibaldi, Biopharmaceutics & Clinical Pharmacokinetics, Ch.5 (1991) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Chiao, Remington, Ch. 94 - Sustained Release (1995) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Winters, Basic Clinical Pharmacokinetics (1994) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Hendeles, J. Allergy Clin. Immunol., 72_7_43-751 (1986) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Koziolek, Advanced Drug Delivery Reviews 101_75¿¿¿88 (2016) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Swanson, Clin. Pharmacol. Therap., 66_95-305 (1999) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Percel, US 2003-0157173A1 | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Couch, WO 2004-028509A1 | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
DECLARATION OF BERNHARDT L. TROUT, Ph.D. (with CV) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
FDA Orange Book Listing for MYDAYIS¿¿ (NDA N022063) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Amidon, U.S. Patent No. 5,229,131 | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Mehta, U.S. Patent No. 5,837,284 | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
IPR2017-00011 Decision Denying Institution (RE41, 148 (300 Patent) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Ansel, Popovich & Allen 6th, Ch. 3-5 (1995) Part 1 | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Ansel, Popovich & Allen 6th, Ch. 3-5 (1995) Part 2 | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Sonsalia, Remington Ch. 74, - CNS Stimulants (1995) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Robinson, Remington, Ch. 94 - Sustained Release (1995) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Porter, Remington, Ch. 93 - Coating (1995) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Franz, Remington Vol. II, Ch. 57 - Sympathomimetic Drugs (1995) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Malinowsi, Remington, Ch. 53 - Bioequivalence (2000) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
USP 23 NF 18 - Uniformity Sec. 905 (1955) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
USP 23 NF 18 1995 - Excerpts (1955) Part 1 | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
USP 23 NF 18 1995 - Excerpts (1955) Part 2 | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Spencer, Arch Gen Psych, 58775-78 (2001 Aug) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Lehninger, Principles of Biochemistry, Excerpt (1993) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Benet, Toxicologic Pathology, 23_115-123 (1995) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Shargel, Applied Bio & Pharmacokinetics, Ch. 2 (1999) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Patent Owner's Preliminary Response [Public] | Apr 10, 2018 | PAPER | PATENT OWNER |
Hinsvark, J. Pharmacokin. Biopharm., 1_319-328 (1973) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Benet, Transplantation Proc., 31 (Suppl 3A), 7S-9S (1999) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Rowland, Clinical Pharmacokinetics 2d (1989) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Mircioiu, Basic & Clinical Pharmacology & Toxicology, 96_262¿¿¿264 (2005) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Booijink, Future Microbiol. 2(3), 285-295 (2007) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Fischer, Pharm. Res., 4_480-485 (1987) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Gupta and Robinson, Controlled Release Delivery (1992) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Macheras, Oral Drug Absorption, Ch. 6 - Modeling Biopharm. (2006) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Schug, European J. Pharm. Sci., 15_279-285 (2002) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
FDA Use & Limitations of In Vitro Testing (Excerpts) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Guidance for Industry ER Formulations IVIVC (1997) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Amidon, Mol. Pharm., 7_1361 (2010) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Khan, International Journal of Pharmaceutics 140_131-143 (1996) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Chasseaud, Ann. Rev. Pharmacol., 14_35-46 (1974) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Greenhill, J. Am. Acad. Child Adolesc. Psychiatry, 42_1234-1241 (2003) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Spencer, Current Diagn & Treatment Psych., Ch 35 - ADHD (2008) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Decision re Institution of IPR2015-02009 | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Gibaldi, Biopharmaceutics & Clinical Pharmacokinetics, Ch. 7 - (1991) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Gibaldi, Biopharmaceutics & Clinical Pharmacokinetics, Appendix II Super-position (1991) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Shire, Q3 2017 MYDAYIS Results (Excerpts) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Brauer, J. Clin. Pharm. 16-1, 72-76 (1996) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Auiler, Curr. Med. Res. Opin., 18_311-316 (2002) | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Protective Order | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Shire, ER and IR Utilization in Adult ADHD [CONFIDENTIAL] | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Shire, MYDAYIS Performance [CONFIDENTIAL] | Apr 10, 2018 | EXHIBIT | PATENT OWNER |
Patent Owner's Motion to Seal | Apr 10, 2018 | PAPER | PATENT OWNER |
Corrected Petition for Inter Partes Review | Jan 11, 2018 | PAPER | PETITIONER |
Notice of Accord Filing Date | Jan 10, 2018 | PAPER | BOARD |
Motion for Pro Hac Vice Chad Landmon | Jan 9, 2018 | PAPER | PETITIONER |
1041 Declaration of Chad Landmon in support of Pro Hac Vice | Jan 9, 2018 | EXHIBIT | PETITIONER |
Motion for Pro Hac Vice Thomas Hedemann | Jan 9, 2018 | PAPER | PETITIONER |
1042 Declaration of Thomas Hedemann in support of Pro Hac Vice | Jan 9, 2018 | EXHIBIT | PETITIONER |
Patent Owner Mandatory Notices | Dec 29, 2017 | PAPER | PATENT OWNER |
Petition for Inter Partes Review for Patent No. 9,173,857 | Dec 11, 2017 | PAPER | PETITIONER |
1003- PDR 2004 Adderall | Dec 11, 2017 | EXHIBIT | PETITIONER |
1004- Declaration of Diane J. Burgess | Dec 11, 2017 | EXHIBIT | PETITIONER |
1005- File History of US Patent No. 8,846,100 part 1 | Dec 11, 2017 | EXHIBIT | PETITIONER |
1005- File History of US Patent No. 8,846,100 part 2 | Dec 11, 2017 | EXHIBIT | PETITIONER |
1007- Chang 1987 | Dec 11, 2017 | EXHIBIT | PETITIONER |
1009- Orange Book Approved Drug Products Adderall | Dec 11, 2017 | EXHIBIT | PETITIONER |
1010- Kratochvil | Dec 11, 2017 | EXHIBIT | PETITIONER |
1011- Heal, Amphetamine Past and Present | Dec 11, 2017 | EXHIBIT | PETITIONER |
1012- Bradley | Dec 11, 2017 | EXHIBIT | PETITIONER |
1014- Tulloch- Adderall XR | Dec 11, 2017 | EXHIBIT | PETITIONER |
1016- US Patent No. 5,326,570 | Dec 11, 2017 | EXHIBIT | PETITIONER |
Power of Attorney | Dec 11, 2017 | PAPER | PETITIONER |
1001-US 9,173,857 | Dec 11, 2017 | EXHIBIT | PETITIONER |
1002- US 6,605,300 | Dec 11, 2017 | EXHIBIT | PETITIONER |
1006- Declaration of William J. Jusko | Dec 11, 2017 | EXHIBIT | PETITIONER |
1008- Adderall 1996 Approval Letter | Dec 11, 2017 | EXHIBIT | PETITIONER |
1013- Drugs @ FDA Approved Drug Products Adderall XR | Dec 11, 2017 | EXHIBIT | PETITIONER |
1015- US Patent No. 4,728,512 | Dec 11, 2017 | EXHIBIT | PETITIONER |
1023- US Patent application No. 10 353,073 | Dec 11, 2017 | EXHIBIT | PETITIONER |
1026- Wagner | Dec 11, 2017 | EXHIBIT | PETITIONER |
1028- HPE (2d ed.) 1994 | Dec 11, 2017 | EXHIBIT | PETITIONER |
1032- Adderall IR Label 2005 | Dec 11, 2017 | EXHIBIT | PETITIONER |
1017- US Patent No. 8,313,776 | Dec 11, 2017 | EXHIBIT | PETITIONER |
1018- US Patent No. 6,555,136 | Dec 11, 2017 | EXHIBIT | PETITIONER |
1019- US Patent No. 6,322,819 | Dec 11, 2017 | EXHIBIT | PETITIONER |
1020- FDA Review 2002 Adderall | Dec 11, 2017 | EXHIBIT | PETITIONER |
1021- Orange Book Approved Drug Products Adderall XR | Dec 11, 2017 | EXHIBIT | PETITIONER |
1022- Gilman 1990 | Dec 11, 2017 | EXHIBIT | PETITIONER |
1024- Agyilirah 1991 | Dec 11, 2017 | EXHIBIT | PETITIONER |
1025- Chambliss 1983 | Dec 11, 2017 | EXHIBIT | PETITIONER |
1027- Limmer 2000 | Dec 11, 2017 | EXHIBIT | PETITIONER |
1029- HPE (3d ed.) 2000 | Dec 11, 2017 | EXHIBIT | PETITIONER |
1030- File History of US Patent No. 9,173,857 | Dec 11, 2017 | EXHIBIT | PETITIONER |
1031- Adderall Label 2004 | Dec 11, 2017 | EXHIBIT | PETITIONER |
1033- Clausen 2005 | Dec 11, 2017 | EXHIBIT | PETITIONER |
1034- WO 1999066904 | Dec 11, 2017 | EXHIBIT | PETITIONER |
1035- WO 1998027967 | Dec 11, 2017 | EXHIBIT | PETITIONER |
1036- Reply Markman brief by Shire | Dec 11, 2017 | EXHIBIT | PETITIONER |
1037- McCracken | Dec 11, 2017 | EXHIBIT | PETITIONER |
1038- Wilson in Oral Drug Absorption Prediction and Assessment (2000) | Dec 11, 2017 | EXHIBIT | PETITIONER |
1039- Fallingborg 1999 | Dec 11, 2017 | EXHIBIT | PETITIONER |
1040- Fallingborg 1990 | Dec 11, 2017 | EXHIBIT | PETITIONER |